Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jinxin Fertility GroupHKSE:01951 -2.26%81 Piotroski F-Score is 3 as of Aug. 10, 2026, which is 50% below its 10-year median of 6.00. GuruFocus rates HKSE:01951 with a GF Score™ of 81/100 and a GF Value™ of HK$3.74 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 643 Healthcare Providers & Services companies, Jinxin Fertility Group ranks worse than 83.36% on this metric.
Warning Sign:
Piotroski F-Score of 3 is low, which usually implies poor business operation.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Jinxin Fertility Group has an F-score of 3. It is a bad or low score, which usually implies poor business operation.
The historical rank and industry rank for Jinxin Fertility Group's Piotroski F-Score or its related term are showing as below:
HKSE:01951'
s Piotroski F-Score Range Over the Past 10 Years
Min: 3 Med: 6 Max: 8
Current: 3
During the past 10 years, the highest Piotroski F-Score of Jinxin Fertility Group was 8. The lowest was 3. And the median was 6.
Jinxin Fertility Group (HKSE:01951) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Jinxin Fertility Group Piotroski F-Score Related Terms
Jinxin Fertility Group Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for Jinxin Fertility Group's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01951 vs HCA, THC, DVA: Piotroski F-Score Comparison
For the Medical Care Facilities subindustry, Jinxin Fertility Group's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jinxin Fertility Group Piotroski F-Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Jinxin Fertility Group's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Jinxin Fertility Group's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Jinxin Fertility Group's current Net Income (TTM) was -1,078.
==> Negative ==> Score 0.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Jinxin Fertility Group's return on assets of this year was -0.06741667. Jinxin Fertility Group's return on assets of last year was 0.0185512.
==> Last year is higher ==> Score 0.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Jinxin Fertility Group's gearing of this year was 0.15276847. Jinxin Fertility Group's gearing of last year was 0.08424856.
==> Last year is lower than this year ==> Score 0.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Jinxin Fertility Group's current ratio of this year was 0.86707233. Jinxin Fertility Group's current ratio of last year was 0.51425065.
==> This year's current ratio is higher. ==> Score 1.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Jinxin Fertility Group's number of shares in issue this year was 2742.365. Jinxin Fertility Group's number of shares in issue last year was 2719.182.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Jinxin Fertility Group's gross margin of this year was 0.33466074. Jinxin Fertility Group's gross margin of last year was 0.3910425.
==> Last year's gross margin is higher ==> Score 0.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Jinxin Fertility Group's asset turnover of this year was 0.18295595. Jinxin Fertility Group's asset turnover of last year was 0.18424109.
==> Last year's asset turnover is higher ==> Score 0.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
0
+
1
+
0
+
1
+
0
+
1
+
0
+
0
+
0
=
3
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Jinxin Fertility Group has an F-score of 3. It is a bad or low score, which usually implies poor business operation.
Jinxin Fertility Group (HKSE:01951) has a Piotroski F-Score of 3 as of Aug. 10, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Jinxin Fertility Group and its competitors. This is 50% below median its historical median of 6.00. Over the past decade, Jinxin Fertility Group's Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, Jinxin Fertility Group ranks #536 out of 643 companies in the Healthcare Providers & Services industry, placing it in the top 83.4%.
Is Jinxin Fertility Group's Piotroski F-Score too high?
Jinxin Fertility Group's current Piotroski F-Score of 3 is 50% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Jinxin Fertility Group's value of 3 is 40% below this industry median. Based on the distribution chart, Jinxin Fertility Group ranks #536 out of 643 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Jinxin Fertility Group has a GF Score™ of 81/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Jinxin Fertility Group's Piotroski F-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jinxin Fertility Group ranks #536 out of 643 companies for Piotroski F-Score. This places Jinxin Fertility Group in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Jinxin Fertility Group's value of 3 is 40% below this benchmark. Historically, Jinxin Fertility Group's own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Jinxin Fertility Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 643 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jinxin Fertility Group's current Piotroski F-Score of 3 is 40% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Jinxin Fertility Group and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jinxin Fertility Group's current Piotroski F-Score is 3, which is 50% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jinxin Fertility Group stock overvalued right now?
Based on GuruFocus' analysis, Jinxin Fertility Group (HKSE:01951) is currently considered Possible Value Trap. The stock's GF Value™ is HK$3.74, compared to a current price of HK$2.16 — trading 42.2% below its estimated fair value. The current Piotroski F-Score is 3, which is 50% below median its 10-year median of 6.00 and 40% below the Healthcare Providers & Services industry median of 5.00. Jinxin Fertility Group's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Jinxin Fertility Group (HKSE:01951), the current Piotroski F-Score is 3 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jinxin Fertility Group (HKSE:01951) Overvalued in 2026?
Based on GuruFocus' analysis, Jinxin Fertility Group stock appears to be undervalued.
The current stock price of HK$2.16 is trading 42.2% below its estimated GF Value™ of HK$3.74.
GuruFocus considers Jinxin Fertility Group to be Possible Value Trap.
Key valuation signals for HKSE:01951:
Piotroski F-Score: 3 (50% below median its 10-year median of 6.00)
GF Value™: HK$3.74 vs. price of HK$2.16 (42.2% below fair value)
Industry Position: 40% below the Healthcare Providers & Services median (#536 of 643)
No single metric tells the full story. See the HKSE:01951 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jinxin Fertility Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in providing IVF services in both China and the United States. The firm, through its subsidiary, is engaged in Assisted reproductive services, management services, ambulatory surgery centre facilities services, obstetrics, gynecology & pediatrics medical services, sales of medical consumables and equipment. and ancillary medical services. Geographically, the company generates a majority of its revenue from Greater China, with a small portion of revenue generated from Overseas Business.
81GF Score
Get the complete analysis for HKSE:01951
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01951 has been successfully added to your 
